Should You Invest in This Big British Pharmaceutical Company? - Motley Fool

14-10-2013 Motley FoolComments (0)

GlaxoSmithKlinePharmaceutical

There isn't much love for big pharmaceutical companies these days. Patent cliffs, uncertain pipelines, and drastic downsizing efforts aren't exactly appealing reasons to invest in this sector. The British giants, GlaxoSmithKline (NYSE: GSK ) and ...

Read more on Motley Fool

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top